Drug Type Immune stimulating antibody conjugate (ISAC) |
Synonyms Boltbody ISAC BDC-1001, BDC 1001, BDC-1001 |
Target |
Mechanism HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators), TLR7 agonists(Toll like receptor 7 agonists), TLR8 agonists(Toll like receptor 8 agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic human epidermal growth factor 2 positive carcinoma of breast | Phase 2 | US | 30 Nov 2023 | |
Metastatic human epidermal growth factor 2 positive carcinoma of breast | Phase 2 | ES | 30 Nov 2023 | |
Advanced Malignant Solid Neoplasm | Phase 2 | US | 24 Feb 2020 | |
Advanced Malignant Solid Neoplasm | Phase 2 | FR | 24 Feb 2020 | |
Advanced Malignant Solid Neoplasm | Phase 2 | KR | 24 Feb 2020 | |
Advanced Malignant Solid Neoplasm | Phase 2 | ES | 24 Feb 2020 | |
HER2 Positive Breast Cancer | Phase 2 | FR | 24 Feb 2020 | |
HER2 Positive Breast Cancer | Phase 2 | KR | 24 Feb 2020 | |
HER2 Positive Colorectal Cancer | Phase 2 | US | 24 Feb 2020 | |
HER2 Positive Colorectal Cancer | Phase 2 | FR | 24 Feb 2020 |
Phase 2 | 231 | pxzwvcntsq(hieyjmsmov) = hxeeekoevn umnzkcpruz (xmjerdgltq ) View more | Positive | 02 Nov 2023 | |||
pxzwvcntsq(hieyjmsmov) = bngzpkqfzh umnzkcpruz (xmjerdgltq ) View more | |||||||
NCT04278144 (ESMO2023) Manual | Phase 1/2 | Solid tumor HER2 Expression | 131 | pkhaajxvgd(eptlzownmn) = gyicfsargr vmvyjuhmvq (fdlklvpfsv ) View more | Positive | 23 Oct 2023 | |
pkhaajxvgd(eptlzownmn) = hzmffbqxcb vmvyjuhmvq (fdlklvpfsv ) View more | |||||||
NCT04278144 (ASCO2023) Manual | Phase 1/2 | HER2 Positive Solid Tumors HER2 Expressing | 118 | cfwoditsaj(okxtrtoeau) = A related SAE (Gr4, bronchopulmonary hemorrhage) was seen in 1 pt (mono, 1.1%). tsnazdvmdt (yqsdhmkibs ) View more | Positive | 26 May 2023 | |
Phase 1/2 | 20 | btudtvaztr(gqdizwlxgm) = mild to moderate yyntvmxpsk (bitqdbdxai ) | - | 28 May 2021 |